X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TORRENT PHARMA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TORRENT PHARMA NOVARTIS/
TORRENT PHARMA
 
P/E (TTM) x 347.0 26.6 1,304.3% View Chart
P/BV x 17.1 6.5 262.2% View Chart
Dividend Yield % 1.7 3.1 55.1%  

Financials

 NOVARTIS   TORRENT PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-16
TORRENT PHARMA
Mar-16
NOVARTIS/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs9821,720 57.1%   
Low Rs5561,134 49.1%   
Sales per share (Unadj.) Rs252.9394.5 64.1%  
Earnings per share (Unadj.) Rs62.1101.8 61.1%  
Cash flow per share (Unadj.) Rs63.3116.3 54.4%  
Dividends per share (Unadj.) Rs10.0040.00 25.0%  
Dividend yield (eoy) %1.32.8 46.4%  
Book value per share (Unadj.) Rs363.6200.3 181.6%  
Shares outstanding (eoy) m31.96169.22 18.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.03.6 84.1%   
Avg P/E ratio x12.414.0 88.3%  
P/CF ratio (eoy) x12.212.3 99.1%  
Price / Book Value ratio x2.17.1 29.7%  
Dividend payout %16.139.3 40.9%   
Avg Mkt Cap Rs m24,580241,435 10.2%   
No. of employees `0000.810.9 6.9%   
Total wages/salary Rs m1,8018,559 21.0%   
Avg. sales/employee Rs Th10,748.96,129.6 175.4%   
Avg. wages/employee Rs Th2,395.2785.8 304.8%   
Avg. net profit/employee Rs Th2,641.11,581.3 167.0%   
INCOME DATA
Net Sales Rs m8,08366,764 12.1%  
Other income Rs m8292,156 38.5%   
Total revenues Rs m8,91368,920 12.9%   
Gross profit Rs m23427,204 0.9%  
Depreciation Rs m372,461 1.5%   
Interest Rs m21,859 0.1%   
Profit before tax Rs m1,02525,041 4.1%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,696-1,403 -120.9%   
Tax Rs m7526,414 11.7%   
Profit after tax Rs m1,98617,224 11.5%  
Gross profit margin %2.940.7 7.1%  
Effective tax rate %73.425.6 286.4%   
Net profit margin %24.625.8 95.2%  
BALANCE SHEET DATA
Current assets Rs m12,67846,622 27.2%   
Current liabilities Rs m2,43332,843 7.4%   
Net working cap to sales %126.720.6 614.1%  
Current ratio x5.21.4 367.1%  
Inventory Days Days3374 44.0%  
Debtors Days Days2279 28.5%  
Net fixed assets Rs m6939,029 0.2%   
Share capital Rs m160846 18.9%   
"Free" reserves Rs m11,46031,400 36.5%   
Net worth Rs m11,62133,890 34.3%   
Long term debt Rs m018,637 0.0%   
Total assets Rs m14,40090,136 16.0%  
Interest coverage x570.514.5 3,942.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.7 75.8%   
Return on assets %13.821.2 65.2%  
Return on equity %17.150.8 33.6%  
Return on capital %23.648.5 48.6%  
Exports to sales %0.743.3 1.7%   
Imports to sales %18.66.9 270.8%   
Exports (fob) Rs m6028,934 0.2%   
Imports (cif) Rs m1,5034,584 32.8%   
Fx inflow Rs m18629,185 0.6%   
Fx outflow Rs m1,8216,021 30.2%   
Net fx Rs m-1,63523,165 -7.1%   
CASH FLOW
From Operations Rs m2,53127,132 9.3%  
From Investments Rs m-8,270-7,014 117.9%  
From Financial Activity Rs m-386-14,352 2.7%  
Net Cashflow Rs m-6,1255,767 -106.2%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 7.0 28.5%  
FIIs % 1.6 12.6 12.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 8.8 244.3%  
Shareholders   41,647 26,511 157.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 17, 2017 03:24 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS